Announced Wed, 22 Apr · 18:17 IST
Anthem Biosciences: New auditor appointed, upside sharing arrangement approved
Management Changes View source PDF
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹758.00
prior close
₹751.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2+1.2+1.0+1.5-2.4+1.6+2.2+1.6+0.3+0.9+3.2+0.6+2.0+3.2
Up moveDown movePending
AI summary
The Board of Anthem Biosciences approved two items: (1) Appointment of S.R. Batliboi & Associates LLP as new Statutory Auditors for 5 years (FY27 to FY32 AGM), replacing K.P. Rao & Co. whose term ends at the 20th AGM in FY27. (2) Approval of an Upside Sharing Arrangement where the Investor Viridity Tone LLP, which sold 20,313,795 shares on March 9, 2026 for INR 13,170 million, will share INR 1,276.83 million with promoter directors. Both items need shareholder approval.
Likely market impact
Routine auditor rotation. Upside sharing of INR 1,276.83 mn to promoters reflects pre-listing investor exit, a minor cash outflow from promoters.